BRPI0012675B8 - - Google Patents

Info

Publication number
BRPI0012675B8
BRPI0012675B8 BR0012675A BR0012675A BRPI0012675B8 BR PI0012675 B8 BRPI0012675 B8 BR PI0012675B8 BR 0012675 A BR0012675 A BR 0012675A BR 0012675 A BR0012675 A BR 0012675A BR PI0012675 B8 BRPI0012675 B8 BR PI0012675B8
Authority
BR
Brazil
Application number
BR0012675A
Other languages
Portuguese (pt)
Other versions
BRPI0012675B1 (pt
BR0012675A (pt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BRPI0012675B1 publication Critical patent/BRPI0012675B1/pt
Publication of BR0012675A publication Critical patent/BR0012675A/pt
Publication of BRPI0012675B8 publication Critical patent/BRPI0012675B8/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/20Interleukins [IL]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/395Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/07Tetrapeptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244Interleukins [IL]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/505Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BR0012675-6A 1999-07-22 2000-07-17 Uso de inibidores de il-18 BR0012675A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IL13104799A IL131047A0 (en) 1999-07-22 1999-07-22 Use of il-18 inhibitors
IL131047 1999-07-22
PCT/IL2000/000419 WO2001007480A2 (en) 1999-07-22 2000-07-17 Use of interleukin-18 inhibitors to inhibit tumor metastasis

Publications (3)

Publication Number Publication Date
BRPI0012675B1 BRPI0012675B1 (pt) 2001-02-01
BR0012675A BR0012675A (pt) 2002-04-09
BRPI0012675B8 true BRPI0012675B8 (US07585860-20090908-C00162.png) 2021-05-25

Family

ID=11073044

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0012675-6A BR0012675A (pt) 1999-07-22 2000-07-17 Uso de inibidores de il-18

Country Status (31)

Country Link
US (1) US7741276B2 (US07585860-20090908-C00162.png)
EP (1) EP1206274B1 (US07585860-20090908-C00162.png)
JP (1) JP4827352B2 (US07585860-20090908-C00162.png)
KR (1) KR100682219B1 (US07585860-20090908-C00162.png)
CN (1) CN1173736C (US07585860-20090908-C00162.png)
AR (1) AR024907A1 (US07585860-20090908-C00162.png)
AT (1) ATE363288T1 (US07585860-20090908-C00162.png)
AU (1) AU782478B2 (US07585860-20090908-C00162.png)
BG (1) BG65800B1 (US07585860-20090908-C00162.png)
BR (1) BR0012675A (US07585860-20090908-C00162.png)
CA (1) CA2380216C (US07585860-20090908-C00162.png)
CY (1) CY1107932T1 (US07585860-20090908-C00162.png)
CZ (1) CZ302114B6 (US07585860-20090908-C00162.png)
DE (2) DE60035049T2 (US07585860-20090908-C00162.png)
DK (1) DK1206274T3 (US07585860-20090908-C00162.png)
EA (1) EA005419B1 (US07585860-20090908-C00162.png)
EE (1) EE04838B1 (US07585860-20090908-C00162.png)
ES (1) ES2186596T3 (US07585860-20090908-C00162.png)
HK (1) HK1048248B (US07585860-20090908-C00162.png)
HU (1) HU228780B1 (US07585860-20090908-C00162.png)
IL (2) IL131047A0 (US07585860-20090908-C00162.png)
MX (1) MXPA02000838A (US07585860-20090908-C00162.png)
NO (1) NO329827B1 (US07585860-20090908-C00162.png)
NZ (1) NZ516535A (US07585860-20090908-C00162.png)
PL (1) PL202477B1 (US07585860-20090908-C00162.png)
PT (1) PT1206274E (US07585860-20090908-C00162.png)
SK (1) SK287522B6 (US07585860-20090908-C00162.png)
TR (1) TR200200169T2 (US07585860-20090908-C00162.png)
UA (1) UA73745C2 (US07585860-20090908-C00162.png)
WO (1) WO2001007480A2 (US07585860-20090908-C00162.png)
ZA (1) ZA200200390B (US07585860-20090908-C00162.png)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101111103B1 (ko) 2000-02-10 2012-02-13 아보트 러보러터리즈 사람 인터류킨-18에 결합하는 항체 및 이를 제조하고 사용하는 방법
EP1331943A4 (en) 2000-10-11 2005-01-26 Viron Therapeutics Inc NUCLEIC ACID MOLECULES AND POLYPEPTIDES FOR IMMUNOMODULATION
US7718368B2 (en) 2000-12-04 2010-05-18 Viron Therapeutics Inc. Immunomodulatory protein and useful embodiments thereof
ES2416510T3 (es) * 2002-10-08 2013-08-01 Ares Trading S.A. Uso de una citocina capaz de unirse a IL 18BP y de inhibir la actividad de una segunda citocina
US7968684B2 (en) 2003-11-12 2011-06-28 Abbott Laboratories IL-18 binding proteins
US7691611B2 (en) 2005-06-03 2010-04-06 Ares Trading S.A. Production of recombinant IL-18 binding protein
JP5091127B2 (ja) 2005-06-10 2012-12-05 アレス トレーディング ソシエテ アノニム Il−18結合タンパク質の精製のための方法
CL2008002153A1 (es) 2007-07-24 2009-06-05 Amgen Inc Anticuerpo aislado o fragmanto de unión de antigeno del mismo que se une al receptor de il-18 (il-18r); molecula de ácido nucleico codificante; celula huesped que la comprende; composición farmaceutica; uso médico para tratar o prevenir una condición asociada con il-18r; método in vitro para inhibir la unión de il-18 al il-18r.
US9812033B2 (en) * 2013-03-06 2017-11-07 Venkatesh R. Chari Tactile graphic display
AU2023236289A1 (en) 2022-03-15 2024-08-15 Compugen Ltd. Il-18bp antagonist antibodies and their use in monotherapy and combination therapy in the treatment of cancer

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994005333A1 (en) * 1992-09-02 1994-03-17 Isis Pharmaceuticals, Inc. Oligonucleotide modulation of cell adhesion
US7141393B2 (en) * 1996-12-26 2006-11-28 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Interleukin-18-receptor proteins
SK122199A3 (en) * 1997-03-18 2000-12-11 Basf Ag Methods and compositions for modulating responsiveness to corticosteroids
IL121860A0 (en) * 1997-08-14 1998-02-22 Yeda Res & Dev Interleukin-18 binding proteins their preparation and use

Also Published As

Publication number Publication date
TR200200169T2 (tr) 2002-06-21
DE60035049T2 (de) 2007-09-27
IL131047A0 (en) 2001-01-28
IL147675A (en) 2009-05-04
US7741276B2 (en) 2010-06-22
KR20020027493A (ko) 2002-04-13
MXPA02000838A (es) 2002-07-30
WO2001007480A3 (en) 2001-05-10
DE60035049D1 (de) 2007-07-12
CY1107932T1 (el) 2013-09-04
JP4827352B2 (ja) 2011-11-30
EA005419B1 (ru) 2005-02-24
UA73745C2 (en) 2005-09-15
PL202477B1 (pl) 2009-06-30
CA2380216A1 (en) 2001-02-01
EP1206274A2 (en) 2002-05-22
HU228780B1 (en) 2013-05-28
PL353732A1 (en) 2003-12-01
HUP0202107A3 (en) 2005-01-28
WO2001007480A2 (en) 2001-02-01
JP2003505472A (ja) 2003-02-12
EA200200189A1 (ru) 2002-12-26
BRPI0012675B1 (pt) 2001-02-01
NO329827B1 (no) 2011-01-03
CA2380216C (en) 2012-01-31
BG65800B1 (bg) 2009-12-31
BG106311A (en) 2002-08-30
ZA200200390B (en) 2003-04-30
DE1206274T1 (de) 2002-11-14
NZ516535A (en) 2004-04-30
AU782478B2 (en) 2005-08-04
AR024907A1 (es) 2002-10-30
NO20020153L (no) 2002-03-11
CN1173736C (zh) 2004-11-03
BR0012675A (pt) 2002-04-09
KR100682219B1 (ko) 2007-02-12
CZ2002195A3 (cs) 2002-06-12
AU5843200A (en) 2001-02-13
ES2186596T3 (es) 2007-11-16
EP1206274B1 (en) 2007-05-30
CN1364086A (zh) 2002-08-14
SK882002A3 (en) 2002-07-02
EE04838B1 (et) 2007-06-15
ATE363288T1 (de) 2007-06-15
HUP0202107A2 (en) 2002-10-28
NO20020153D0 (no) 2002-01-11
PT1206274E (pt) 2007-07-06
HK1048248B (zh) 2005-04-22
DK1206274T3 (da) 2007-08-13
SK287522B6 (sk) 2011-01-04
EE200200032A (et) 2003-02-17
CZ302114B6 (cs) 2010-10-20
ES2186596T1 (es) 2003-05-16
US20080003216A1 (en) 2008-01-03
HK1048248A1 (en) 2003-03-28

Similar Documents

Publication Publication Date Title
BE2018C020I2 (US07585860-20090908-C00162.png)
BE2016C007I2 (US07585860-20090908-C00162.png)
BE2015C057I2 (US07585860-20090908-C00162.png)
BE2015C018I2 (US07585860-20090908-C00162.png)
BE2014C017I2 (US07585860-20090908-C00162.png)
BE1025464I2 (US07585860-20090908-C00162.png)
JP2002520706A5 (US07585860-20090908-C00162.png)
JP2002529779A5 (US07585860-20090908-C00162.png)
BRPI0017527B8 (US07585860-20090908-C00162.png)
BRPI0001672A2 (US07585860-20090908-C00162.png)
BRPI0001542A2 (US07585860-20090908-C00162.png)
JP2002514524A5 (US07585860-20090908-C00162.png)
BRPI0012675B8 (US07585860-20090908-C00162.png)
BRPI0017522A2 (US07585860-20090908-C00162.png)
JP2001112885A5 (US07585860-20090908-C00162.png)
HU0004673D0 (US07585860-20090908-C00162.png)
BRMU7902607U2 (US07585860-20090908-C00162.png)
JP2002525851A5 (US07585860-20090908-C00162.png)
IN192072B (US07585860-20090908-C00162.png)
CN3097510S (US07585860-20090908-C00162.png)
CN3097509S (US07585860-20090908-C00162.png)
CN3098432S (US07585860-20090908-C00162.png)
CN3098431S (US07585860-20090908-C00162.png)
CN3098238S (US07585860-20090908-C00162.png)
CN3098701S (US07585860-20090908-C00162.png)

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Free format text: ARES TRADING S.A. (CH)

B25G Requested change of headquarter approved

Owner name: ARES TRADING S.A. (CH)

Free format text: SEDE ALTERADA CONFORME SOLICITADO NA PETICAO NO 020040005826 DE 28/10/2004

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O C/C 13 E 25 DA LPI.

B12B Appeal against refusal [chapter 12.2 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 02/10/2018, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 17/07/2000 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B21A Patent or certificate of addition expired [chapter 21.1 patent gazette]

Free format text: PATENTE EXTINTA EM 17/07/2020